Key result
The Gar²De²Nia risk score demonstrated a sensitivity of 91.43% and specificity of 73.33% for predicting significant coronary stenosis in a pilot cohort of 100 patients.
Why the study?
Risk prediction models and online calculators assist decision making and personalized preventive care, prompting the design of a score to predict significant coronary stenosis in patients without proven CAD or after revascularization.
Does the Gar²De²Nia risk score accurately predict significant coronary stenosis in patients without proven CAD or those previously revascularized?
Observational (n=100)
No
Does the Gar²De²Nia risk score accurately predict significant coronary stenosis in patients without proven CAD or those previously revascularized?
The Gar²De²Nia risk score is a simple, web-based clinical tool that shows promising initial diagnostic accuracy for predicting significant coronary stenosis.
Answers are grounded in this paper and cite their sources.
Supports validation of the Gar²De²Nia score; should not yet change practice in CAD evaluation.
Objectives: Gar²De²Nia score is designed to predict highly suspicious probability of significant coronary stenosis in patients without proven CAD or those who have already been revascularized. Background: There are a large number of scores that are used for cardiovascular risk assessment and different online calculators are used to perform it. Risk prediction models provide risk estimates that can assist our decision making and improve guiding for individual clinical outcomes and personalized preventive care. Methodology: Gar²De²Nia is an acronym that incorporates following parameters: Gender, Age, Renal impairement, Respiratory disease, Diabetes Melittus, Echo abnormalities, ECG abnormalities, new symptoms, Ischaemia, Atrial fibrillation. The pointing scale was formed (-1 to 2) on the personal interpretation of evidence based data and is applied and designed as web calculator. The established cut-off values for the risk of significant coronary stenosis are 4. For values below 4, the probability of significant CAD is low, below 0 is very low, equal or greater than 4 significant CAD is high and above 8 is very high. https://www.gardenia.estavela.in. Results: Standard statistical formulas for sensitivity, specificity, PPN and NPV were used (sensitivity 91, 43%, specificity 73, 33%, PPV 88, 89, NPV 78, 57). Estimated pilot sample size of 100 patients, was tested on patients cohort treated at the Institute for Cardiovascular Disease Dedinje in the year of 2022. Conclusion: This original score is to be checked throughout everyday clinical practice. It is easy to use. It can help in decision making in risk stratification and further treatment of the patients who has never been to cardiologist before, those who has already been revascularized and are symptomatic again or need any kind of non-cardiac surgery and the patients we have doubts about what to do next.
No takes yet. Share an insight, caveat, or question.
Dragana Šarenac (2023) conducted an observational in Severe Coronary Artery Restenosis (n=100). Gar²De²Nia Risk Score was evaluated on Prediction of significant coronary stenosis (Sensitivity 91.43%, Specificity 73.33%). The Gar²De²Nia risk score demonstrated a sensitivity of 91.43% and specificity of 73.33% for predicting significant coronary stenosis in a pilot cohort of 100 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: